Navigation Links
MAP Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
Date:8/6/2009

ties in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction.

About MAP Pharmaceuticals

MAP Pharmaceuticals is dedicated to developing and commercializing new therapies for patients suffering from conditions that are not adequately treated by currently available medicines. The company is developing LEVADEX inhaled therapy for the potential treatment of migraine and has reported positive results from the efficacy portion of the first Phase 3 trial of LEVADEX. In addition, MAP Pharmaceuticals generates new pipeline opportunities by applying its proprietary drug particle and inhalation technologies to enhance the therapeutic benefits of proven drugs, while minimizing risk by capitalizing on their known safety, efficacy and commercialization history.

Forward-Looking Statements

In addition to statements of historical facts or statements of current conditions, this press release contains forward-looking statements, including with respect to MAP Pharmaceuticals' LEVADEX product candidate and future cash usage. Actual results may differ materially from current expectations based on risks and uncertainties affecting the company's business, including risks related to the failure to achieve favorable clinical outcomes and to have the company's LEVADEX(TM) product candidate approved for commercial use. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law. Additional information on potential factors that could affect MAP Pharmaceuticals' results and other risks and uncertainties are detailed in its Annual Report on Form 10-K for the year ended December 31, 2008, as amended, and its Quarterly
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
2. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
3. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
4. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
5. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
6. ACG Announces Major Gift by Salix Pharmaceuticals, Inc.
7. Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors
8. Elan Pharmaceuticals, Inc. Licenses Software and Databases From GeneGo
9. Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
10. Acura Pharmaceuticals, Inc. Announces Implementation of Reverse Stock Split and New Trading Symbol: ACPH
11. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 31, 2014 USHIO America’s Solid ... and general lighting marketplaces, today announced the launch ... will allow users to transform existing, inefficient lamp-based ... minutes. , USHIO America’s Uphoria LED downlight retrofit ... cans, allowing the user to upgrade old incandescent ...
(Date:7/31/2014)... Thanks to its mildly sweet ... long been used as a medium for delivery ... fruit. However consistent, dependable sourcing of erythritol often ... food and beverage manufacturers’ increasing needs for reliable, ... GMO-free ErysweetTM Erythritol. , “Erysweet is unique ...
(Date:7/30/2014)... Colorado (PRWEB) July 30, 2014 Vail ... skiers wearing orange vests emblazoned with “Blind Skier.” Those ... slopes through Foresight Ski Guides , a non-profit ... visually impaired and blind participants (VIPs) for snow sport ... in guiding can learn more and pick up an ...
(Date:7/30/2014)... CareSource, a nonprofit, Ohio-based health plan, is pleased ... Credit Union, to the CareSource Ohio Board of Trustees. ... an extensive background in leading credit unions. He was ... officer at Wright-Patt Credit Union (WPCU) in Fairborn, Ohio. ... Union that has realized more than seven years of ...
(Date:7/30/2014)... events experienced during deployment, returning National Guard soldiers ... if faced with civilian life setbacks, including job ... legal problemsall commonplace in military families. Results of ... School of Public Health are published online in ... , Alcohol abuse is a major concern for ...
Breaking Medicine News(10 mins):Health News:USHIO America Introduces Uphoria™ LED Downlight Retrofit Kits 2Health News:Steviva Ingredients Launches Erysweet Erythritol 2Health News:Colorado Non-Profit Foresight Ski Guides Seeking Applications for Blind and Visually Impaired Skiers and Guides for Vail Ski Season 2Health News:Vets' alcohol problems linked to stress on the home front 2
... May 11 (HealthDay News) -- Retrieving about 15 eggs from ... cycle offers the best chance of achieving a live birth ... study. Researchers analyzed more than 400,000 IVF cycles in ... strong association between live birth rates and the number of ...
... HealthDay Reporter , TUESDAY, May 10 (HealthDay News) -- ... may lower their risk for developing a particular type of ... of five or more cups of coffee a day to ... ER-negative breast cancer. However, coffee consumption did not appear ...
... 11, 2011Most Maryland residents trust the health and medical ... magazines (68%), radio (66%)and the Internet (also 66%), according ... media fared less well, with 51% saying social media ... Fewer than 20% use their cell phone or other ...
... one day take rides on starch compounds creating ... to Penn State food scientists. The technique may ... more environmentally friendly alternative in creating, among other ... of experiments, researchers formed pockets with corn starch ...
... useful would it be to anticipate how well someone will ... be able to stay calm during stress? To ... of psychology at Case Western Reserve University, finds clues in ... with regard to how well they can control their emotions, ...
... are told, heightens our senses, imprinting sights and sounds ... which appeared in Nature Neuroscience this week, ... learned in an aversive context are not as sharp ... hint that this tendency is rooted in our species, ...
Cached Medicine News:Health News:Number of Eggs Retrieved Helps Predict IVF Success: Study 2Health News:Are Coffee Drinkers Less Prone to Aggressive Breast Cancer? 2Health News:Are Coffee Drinkers Less Prone to Aggressive Breast Cancer? 3Health News:Maryland poll: Traditional media and internet more trusted than social media for research news 2Health News:Maryland poll: Traditional media and internet more trusted than social media for research news 3Health News:Vitamins may hitch a protected ride on corn starch 2Health News:When words get hot, mental multitaskers collect cool 2Health News:When words get hot, mental multitaskers collect cool 3Health News:Weizmann Institute scientists show: How adversity dulls our perceptions 2
(Date:7/30/2014)... WOODCLIFF LAKE, N.J. and SAN DIEGO ... Pharmaceuticals, Inc. (NASDAQ: ARNA ) announced today that ... Phase 3 trials of lorcaserin entitled, "Early Weight Loss While ... 52 Weight-Loss Outcomes," was recently published in the online issue ... The Obesity Society. The objective of these analyses was to ...
(Date:7/30/2014)... NEW YORK , July 30, 2014 ... of new products for oncology supportive care, announced that ... has been featured in an article on OncLive.com titled, ... Head and Neck Cancers."  Dr. Steve Sonis , ... the growing demand seen in the oncology community for ...
(Date:7/30/2014)... July 30, 2014 /PRNewswire-iReach/ -- This is a ... Chinese Heparin sodium (CAS 9041-08-1) & calcium (CAS ... information of Heparin sodium (CAS 9041-08-1) & calcium ... technology. The report then explores global and China,s ... calcium (CAS 37270-89-6) listing their product specification, capacity, ...
Breaking Medicine Technology:Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 2Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 3Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 4Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 5Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 6Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity 7Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 2Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 3Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 4Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 5
... The SR™ Hand Implant System utilizes ... and knee joint replacements. The SR™ ... available in other prostheses including minimal bone ... eroded cartilaginous articular surfaces, retention and/or repositioning ...
For use in implant resection arthroplasty of the trapeziometacarpal joint in cases of rheumatoid, degenerative or post-traumatic arthritis....
The efficient choice for small joint replacement technology -- the Ascension Silicone MCP features a similar design to our PyroCarbon MCP and utilizes the same instrumentation for intra-operative fle...
... Hand Implant System utilizes the same proven ... replacements. The SR™ Hand Implant System ... prostheses including minimal bone resection, surface replacement ... surfaces, retention and/or repositioning of the ligamentous ...
Medicine Products: